期刊文献+

左西孟旦在心外科围术期的心脏保护作用 被引量:3

Cardioprotection of Levosimendan in Perioperative Cardiac Surgery
原文传递
导出
摘要 左西孟旦是一种钙离子增敏剂,可以增加心肌收缩力,扩张外周血管。左西孟旦起效迅速且作用持久,与其活性代谢产物OR-1896有关。可应用于心脏外科手术中保护心脏,减少缺血再灌注损伤,改善术后心脏功能,有效预防和治疗术后低心输出量综合症,提高术后脱离体外循环率。现有研究表明对于左室射血分数下降的患者左西孟旦能减少心脏术后死亡率,但仍需要一个大样本的临床随机对照试验来证明。 Levosimendan,a calcium sensitizer, can increase myocardial contractility and diastole peripheral vascular. It has a rapid onset of effect and long duration of action, which depends on its active metabolites OR - 1896. When applied to cardiac surgery, it can protect the heart from ischemia reperfusion injury and improve the postoperative cardiac function.And also,the prevention and treatment effect on the low cardiac output syndrome is obvious and the rate of weaned from extracorporeal circulation increased after operation. Existing studies have shown that levosimendan can reduce the postoperative mortality of patients with decreased left ventricular ejection fraction, but large sample randomized controlled clinical trials are still needed to get a more clear insight of it.
作者 王萌 王古岩
出处 《中国分子心脏病学杂志》 CAS 2015年第4期1420-1423,共4页 Molecular Cardiology of China
关键词 左西孟旦 钙离子增敏剂 心肌保护 缺血再灌注损伤 Levosimendan Calcium Sensitization Agent Myocardial Protection Ischemia Reperfusion Injury
  • 相关文献

参考文献25

  • 1Erb J, Beutlhauser T, Feldheiser A,et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res. 2014 Apr 29.
  • 2M.S. Nieminen,J.Altenberger, T.Ben-Gal .Repetitive use of levosimcndan for treatment of chronic advanced heart failure : Clinical evidence,practical considerations,and perspectives:An expert panel consensus.International Journal of Cardiology. 174(2014)360-367.
  • 3Krista Siirilfi-Waris,Raili Suojaranta-Ylinen,and Veli- Pekka Harjola.Levosimendan #1 Cardiac Surgeo' Journal of Cardiothoracic and Vascular Anesthesia, Vol 19, No 3 (June), 2005: pp 345-349.
  • 4Follath F, Cleland J G, Just H, Papp J G, Scholz H, Peuhkurinen K. et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196- 202.
  • 5M.S.Nieminen,S.Fruhwald,L.M.A.Heunks.Levosimendan:current data,clinical use and future development Heart,Lung andVessels.2013,Vol.5.
  • 6Retraction: De Heft SG, Lorsomradee S, vanden Eede H, et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vase Anesth 2008;22:699-705.J Cardiothorac Vasc Anesth. 2011 Oct;25(5):897.
  • 7Gandham R, Syamasundar A, Ravulapalli H, et al. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis. Ann CardAnaesth. 2013 Jan-Mar; 16(1 ): 1 1-5.
  • 8Baysal A, Yanartas M, Dogukan M, et al. Levosimendan Improves Renal Outcome in Cardiac Surgery: A Randomized Trial. J Cardiothorac VuscAnesth. 2014 Jan 18.
  • 9De Heft SG, Lorsomradee S, vanden Eede H, et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth. 2008 Oct;22(5):699-705. Epub 2008 May 14.
  • 10. Brezina A, Riha H, Pirk J. Prophylactic application of levosimendan in cardiac surgical patients with severe left ventricle dysfunction. Exp Clin Cardiol. 2009 Summer; 14(2):e31-4.

同被引文献26

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部